Related Experiment Video
Updated: Dec 18, 2025

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
Published on: May 25, 2022
Regulation of Myofilament Contractile Function in Human Donor and Failing Hearts
Kerry S McDonald1, Laurin M Hanft1, Joel C Robinett1
1Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States.
Insights
Heart failure (HF) impairs cardiac function by altering myofibrillar mechanics. In failing hearts, diminished length-dependent regulation of myofilament function contributes to reduced ventricular performance, highlighting a key mechanism in contractile dysfunction.
Area of Science:
- Cardiovascular Physiology
- Myocardial Contractility
- Heart Failure Pathophysiology
Background:
- Heart failure (HF) is characterized by impaired myocardial contractile function.
- Understanding the myofibrillar basis of this dysfunction is crucial for developing targeted therapies.
- Previous studies suggest tissue remodeling contributes to force decline in multicellular HF preparations.
Purpose of the Study:
- To investigate the myofibrillar basis of contractile dysfunction in failing human myocardium.
- To elucidate the role of myofilament calcium (Ca2+) and sarcomere length (SL) dependence in HF.
- To compare contractile properties of cardiac myocytes from donor and failing human hearts.
Main Methods:
- Isolation and permeabilization of cardiac myocytes from human donor and HF left ventricular biopsies.
- Measurement of Ca2+ and SL dependence of force, loaded shortening, and power output using a force transducer and position motor.
- Analysis of peak power output normalized to isometric force (PNPO) under varying Ca2+ and SL conditions.
Main Results:
- Maximal Ca2+-activated isometric force and maximal force development rates were similar between donor and HF myocytes.
- Peak power output normalized to isometric force (PNPO) decreased with reduced Ca2+ activation in both groups.
- The sarcomere length (SL) dependence of PNPO was significantly diminished in failing human myocytes compared to donor myocytes.
Conclusions:
- Contractile dysfunction in failing human myocardium is not due to reduced maximal force or cross-bridge cycling rates at the myocyte level.
- Altered length-dependent regulation of myofilament function, specifically a blunted response of power output to changes in SL, impairs ventricular performance in HF.
- These findings highlight a critical role for altered myofilament calcium sensitivity and length-dependent mechanisms in the pathophysiology of human heart failure.
Abstract:
Heart failure (HF) often includes changes in myocardial contractile function. This study addressed the myofibrillar basis for contractile dysfunction in failing human myocardium. Regulation of contractile properties was measured in cardiac myocyte preparations isolated from frozen, left ventricular mid-wall biopsies of donor (n = 7) and failing human hearts (n = 8). Permeabilized cardiac myocyte preparations were attached between a force transducer and a position motor, and both the Ca2+ dependence and sarcomere length (SL) dependence of force, rate of force, loaded shortening, and power output were measured at 15 ± 1°C. The myocyte preparation size was similar between groups (donor: length 148 ± 10 μm, width 21 ± 2 μm, n = 13; HF: length 131 ± 9 μm, width 23 ± 1 μm, n = 16). The maximal Ca2+-activated isometric force was also similar between groups (donor: 47 ± 4 kN⋅m-2; HF: 44 ± 5 kN⋅m-2), which implicates that previously reported force declines in multi-cellular preparations reflect, at least in part, tissue remodeling. Maximal force development rates were also similar between groups (donor: k = 0.60 ± 0.05 s-1; HF: k = 0.55 ± 0.04 s-1), and both groups exhibited similar Ca2+ activation dependence of k values. Human cardiac myocyte preparations exhibited a Ca2+ activation dependence of loaded shortening and power output. The peak power output normalized to isometric force (PNPO) decreased by ∼12% from maximal Ca2+ to half-maximal Ca2+ activations in both groups. Interestingly, the SL dependence of PNPO was diminished in failing myocyte preparations. During sub-maximal Ca2+ activation, a reduction in SL from ∼2.25 to ∼1.95 μm caused a ∼26% decline in PNPO in donor myocytes but only an ∼11% change in failing myocytes. These results suggest that altered length-dependent regulation of myofilament function impairs ventricular performance in failing human hearts.
Related Concept Videos
Pathophysiology of Cardiac Performance
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inotropic Agents

